Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV07-B) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov
We optimised and validated a method that allows for high throughput virome analysis. For that we evaluated the quantitative effect of homogenisation, centrifugation, filtration, chloroform treatment a
CRISPR/Cas9 technology has revolutionized genetic engineering of primary cells. Although its use is gaining momentum in studies on CD8+ T cell biology, it remains elusive to what extent CRISPR/Cas9 af
